NYSE

Danaher CORP

DHR

3 stories

$153B Market cap · 2026-10-09

This business can always surprise you

Danaher cut 2026 core revenue growth guidance to 3-4% as delayed chromatography resin shipments hit bioprocessing, while life sciences…

DHR $153B

Best Anchor Stocks Jul 29 1 click

@BrokenMoats Jul 23 1 click

Broken Moats on X

$DHR move this week is odd. I know its trading off $TMO today but the bioprocessing is the bigger piece to DHR and those sales/guide were disappointing and you saw weak action from https://t.co/sj9MDhumCh today off their numbers and even $RGEN trading off. $165 - $190 in two days this week seems off. Maybe the initial flush was over done, but hard to argue this business deserves to trade back at 200 where it came into earnings after seeing the bioprocessing commentary. Seems like a fade at 190

Danaher 2Q'26: Yet Another "Meh" Quarter

Danaher posted 3.0% core revenue growth in 2Q’26, with LTM adjusted EBITA flat at $7.1 billion since 2Q’24 despite a mid-20s earnings…

DHR $153B

MBI Deep Dives Jul 22 4 clicks

Investor Letters

Letters that discuss DHR.

Weitz Investment Management Letter to Shareholders: Value Matters third quarter 2025 ACN $118BCNSWF $43BCRM $183B
Rewey Asset Management 2Q26 2Q26 VNT $4.4BOFIX $370MUCTT $3.3B

Tickers on this page

Companies the stories above are also about, besides DHR.

TMO $246B